Literature DB >> 1083719

Sternal osteomyelitis and mediastinitis after open-heart operation: pathogenesis and prevention.

R A Weinstein, E L Jones, S W Schwarzmann, C R Hatcher.   

Abstract

Sternal osteomyelitis and mediastinitis caused by Pseudomonas cepacia developed in a patient undergoing coronary artery bypass two weeks after the operation. P. cepacia bacteremia from a contaminated pressure transducer had preceded and probably caused the chest infection. While other authors have suggested that postoperative sternal osteomyelitis and mediastinitis result from local wound contamination, this case suggests the importance of bacteremia as a cause of such gram-negative infections. Since patients undergoing open-heart operation are exposed to many sources of bacteremia, prevention of severe postoperative chest infections may depend in large part on careful preoperative evaluation of each patienc antibiotic regimens, and, as shown in this patient, on very thorough periodic review of equipment sterilization and intravascular monitoring practices.

Entities:  

Mesh:

Year:  1976        PMID: 1083719     DOI: 10.1016/s0003-4975(10)63896-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

Review 1.  The epidemiology of nosocomial epidemic Pseudomonas cepacia infections.

Authors:  W J Martone; O C Tablan; W R Jarvis
Journal:  Eur J Epidemiol       Date:  1987-09       Impact factor: 8.082

2.  Post-operative mediastinitis in a salmonella carrier.

Authors:  T Aherne
Journal:  Ir J Med Sci       Date:  1984-04       Impact factor: 1.568

3.  Treatment of mediastinitis in children after cardiac surgery. A study of 20 cases.

Authors:  A Barois; S Grosbuis; N Simon; A Combes; J L Bourda; C Chapuis; M Goulon
Journal:  Intensive Care Med       Date:  1978-01       Impact factor: 17.440

4.  Cervical osteomyelitis caused by Pseudomonas cepacia in an intravenous-drug abuser.

Authors:  M A Smith; N R Trowers; R S Klein
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.